Neoadjuvant Therapy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Neoadjuvant Trastuzumab, Pertuzumab and Tucatinib Without Chemotherapy in HER2-positive Breast Cancer: the TRAIN-4 Study
Conditions: Breast Cancer Interventions: Drug: Tucatinib; Drug: Trastuzumab; Drug: Pertuzumab Sponsors: The Netherlands Cancer Institute; Seagen Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Therapy in Rectal Cancer
Conditions: Rectal Cancer Interventions: Radiation: Short-course radiotherapy; Drug: mFOLFOX6 Sponsors: National Cheng-Kung University Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Total Neoadjuvant Therapy for Adenocarcinoma of the OESophagus and Oesophagogastric Junction: TNT-OES-2 Trial
Conditions: Esophageal Cancer; Adenocarcinoma of the Esophagus Interventions: Drug: FLOT-CROSS or CROSS-FLOT Sponsors: Erasmus Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 8, 2023 Category: Research Source Type: clinical trials

Cadonilimab + FOLFOX Versus FOLFOX in the Neoadjuvant Treatment of pMMR/MSS Locally Advanced Colorectal Cancer
Conditions: Locally Advanced Colorectal Carcinoma Interventions: Drug: Cadonilimab; Drug: FOLFOX regimen Sponsors: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials

Organoids Based Drug Sensitivity in Neoadjuvant Chemotherapy of Breast Cancer
Conditions: Organoids; Breast Cancer; Neoadjuvant Chemotherapy Interventions: Procedure: Biopsy Sponsors: Second Affiliated Hospital, School of Medicine, Zhejiang University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 4, 2023 Category: Research Source Type: clinical trials

Neoadjuvant PD-1 Inhibitor Combined With Cetuximab and Platinum in Resectable Locally Advanced Hypopharyngeal Carcinoma
Conditions: Locally Advanced Hypopharyngeal Carcinoma Interventions: Drug: three cycles (toripalimab + cetuximab + platinum); Procedure: Radical surgery; Radiation: Radiotherapy or chemoradiotherapy Sponsors: Eye& ENT Hospital of Fudan University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

Muscle Parameters and Pathological Response in Breast Cancer Patients
Conditions: Neoadjuvant Chemotherapy Interventions: Other: Neoadjuvant therapy Sponsors: Ac ıbadem Atunizade Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma
Conditions: Merkel Cell Carcinoma Interventions: Drug: Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination Sponsors: Melanoma Institute Australia; Bristol-Myers Squibb Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 30, 2023 Category: Research Source Type: clinical trials

Micrometastases in Axillary Lymph Nodes in Breast Cancer, Post-neoadjuvant Chemotherapy
Conditions: Micrometastases; Neoadjuvant Chemotherapy Interventions: Procedure: Sentinel lymph node biopsy, axillary lymph node dissection Sponsors: Gangnam Severance Hospital Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 29, 2023 Category: Research Source Type: clinical trials

Precision Treatment of Recurrent/Metastatic Salivary Gland Carcinoma Guided by Molecular-based Stagingcarcinoma
Conditions: Locally Advanced or Recurrent/Metastatic Salivary Gland Carcinoma; Neoadjuvant or Conversion Therapy; Precision Therapy Interventions: Drug: Vedolizumab; Drug: larotinib or enttraitinib; Drug: antiandrogen drug treatment; Drug: SHR-A1921; Drug: small molecule multi-target tyrosine kinase inhibitors; Drug: albumin paclitaxel with platinum Sponsors: Peking Union Medical College; Peking University Hospital of Stomatology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 24, 2023 Category: Research Source Type: clinical trials

Response to Neoadjuvant Chemoimmunotherapy in Resectable Locally Advanced Oral Cancer
Conditions: Oral Cancer Interventions: Drug: PD-1 inhibitor+carboplatin+albumin-bound paclitaxel Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials

Neoadjuvant Pyrotinib Versus Placebo Combined With Chemotherapy in HR-positive and HER2-low Early Breast Cancer
Conditions: Breast Cancer Invasive; Hormone-receptor-positive Breast Cancer; HER2 Low Breast Carcinoma; Early-stage Breast Cancer Interventions: Drug: Pyrotinib, epirubicin or doxorubicin, cyclophosphamide, paclitaxel; Drug: Placebo, epirubicin or doxorubicin, cyclophosphamide, paclitaxel Sponsors: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University; Jiangsu HengRui Medicine Co., Ltd. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 22, 2023 Category: Research Source Type: clinical trials

Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC
Conditions: Cadonilimab; Clear Cell Renal Cell Carcinoma; Neoadjuvant Therapy Interventions: Drug: Cadonilimab Combined With Lenvatinib Sponsors: Sun Yat-sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Liver Transplantation in Intrahepatic Cholangiocarcinoma
Conditions: Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma; Determine Efficacy of Liver Transplantation After Neoadjuvant Systemic Therapy in Patients With Locally Advanced Non-metastatic Intrahepatic Cholangiocarcinoma Interventions: Procedure: Liver Transplant Sponsors: Rutgers, The State University of New Jersey Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 18, 2023 Category: Research Source Type: clinical trials

Dissecting the Pattern of Nodal Spread in Post-neoadjuvant Pancreatoduodenectomy
Conditions: Pancreas Cancer; Pancreatic Adenocarcinoma Interventions: Procedure: Systematic lymphadenectomy Sponsors: Universita di Verona Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 16, 2023 Category: Research Source Type: clinical trials